PELOSI, NANCY BUYNVDA$500K–$1M·TUBERVILLE, TOMMY BUYMSFT$50K–$100K·CRENSHAW, DAN SELLXOM$15K–$50K·PELOSI, NANCY BUYNVDA$500K–$1M·TUBERVILLE, TOMMY BUYMSFT$50K–$100K·CRENSHAW, DAN SELLXOM$15K–$50K·
← Leaderboard
MRNA
Ticker

MRNA

Moderna Inc.
Healthcare
Congressional Trades
14
by 4 members
Buys
7
50%
Sells
7
50%
Total Volume
$112K
midpoint
Unique Traders
4
members

Party Breakdown

Democrats13 · 93%
Republicans1 · 7%

Party Trading Divergence

Democrat vs. Republican buy / sell pressure by monthHIGH DIVERGENCE

Bar length = total trades. Color = net sentiment — green = net buying, red = net selling. Months with no activity hidden.

Democrat ←
Month
→ Republican
01
Feb '24
01
Mar '24
1
Apr '24
01
Aug '24
1
Oct '24
01
Jan '25
2
Feb '25
1
01
Apr '25
01
May '25
1
Jul '25
01
Aug '25
1
Jan '26
Democrats67Neutral
vs
Republicans10Net buyers
Net buyingNet selling⚡ Party split

💼 Lobbying Filings

all →
  • 2026-04-20$50K
    MODERNATX INC.
    Issues related to COVID 19 vaccines, mRNA drug discovery, drug development and related issues.
  • 2026-04-20$50K
    MODERNA INC.
    Issues related to the Vaccine Injury Compensation Program (VICP); Issues related to vaccine safety and approval; Issues related to FDA's delay in reviewing Moderna's flu vaccine
  • 2026-04-20$20K
    STANTON PARK GROUP LLC ON BEHALF OF MODERNATX INC.
    Issues related to COVID 19 vaccines, mRNA drug discovery, drug development and related issues.
  • 2026-04-18$80K
    MODERNA US INC.
    Issues related to drug discovery, drug development, vaccine technologies, and coverage and reimbursement Issues related to biotechnology legislation and supply chain
  • 2026-04-17$190K
    MODERNA INC.
    Vaccine Policy, FDA Vaccine Approvals
  • 2026-04-15$80K
    MODERNA US INC.
    Issues related to vaccines, drug discovery, development and related issues.
  • 2026-04-10$20K
    MODERNA INC.
    Tax Reform - Restoring the Orphan Drug Tax Credit.
  • 2026-04-01$30K
    MODERNATX INC.
    Issues related to corporate and international taxation. Issues related to OECD Pillar 2 negotiations and agreements on the taxation of global income. Issues related to IRC sections 11, 41, 45C, 951A, 250, and 174. (H.R. 1414).
  • 2026-03-23$100K
    MODERNA INC.
    Vaccine Policy
  • 2026-01-20$50K
    MODERNATX INC.
    Issues related to COVID 19 vaccines, mRNA drug discovery, drug development and related issues.

Congressional Momentum

buy vs. sell pressureNEUTRAL

Score 0–100: above 50 = net buying pressure, below 50 = net selling. Signal based on last 90 days.

Last 30 Days
No trades
Last 90 Days
No trades
All-Time
50
7 buys14 total7 sells
$56K buys · $56K sells
Cumulative Net Position (buy vol − sell vol)
+$0
2024-0214 trades plotted2026-01

Trade Activity Timeline

Congressional buys & sells by month · last 12 months w/ activity

24/02
24/03
24/04
24/08
24/10
25/01
25/02
25/04
25/05
25/07
25/08
26/01
BuysSellsOtherHigh-volume month

Who Moved First

each row = one member · sorted by earliest disclosed trade
2 buyers ·3 sellers
20252026DJosh Gottheimer1×2024-02-01 · sell · $8KDRo Khanna11×2024-03-20 · sell · $8K2024-04-23 · buy · $8K2024-08-02 · sell · $8K2024-10-14 · buy · $8K2025-02-19 · buy · $8K2025-02-25 · buy · $8K2025-04-10 · sell · $8K2025-05-19 · sell · $8K2025-07-25 · buy · $8K2025-08-26 · sell · $8K2026-01-23 · buy · $8KDJulie Johnson1×2025-01-15 · sell · $8KRRobert Bresnahan1×2025-02-25 · buy · $8K
BuySellOtherDot size ∝ trade size · top 4 most-active traders shown

All Disclosed Trades

DateMemberActionAmountFiling Delay
2026-01-23DRo KhannaBUY$1K – $15K14d
2025-08-26DRo KhannaSELL$1K – $15K14d
2025-07-25DRo KhannaBUY$1K – $15K13d
2025-05-19DRo KhannaSELL$1K – $15K22d
2025-04-10DRo KhannaSELL$1K – $15K32d
2025-02-25RRobert BresnahanBUY$1K – $15K30d
2025-02-25DRo KhannaBUY$1K – $15K9d
2025-02-19DRo KhannaBUY$1K – $15K15d
2025-01-15DJulie JohnsonSELL$1K – $15K28d
2024-10-14DRo KhannaBUY$1K – $15K25d
2024-08-02DRo KhannaSELL$1K – $15K35d
2024-04-23DRo KhannaBUY$1K – $15K13d
2024-03-20DRo KhannaSELL$1K – $15K16d
2024-02-01DJosh GottheimerSELL$1K – $15K35d